Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

Journal of Clinical Investigation

Volumn 119, Issue 3, 2009, Pages 565-572

  Bending, David ^a   De La Peña, Hugo ^a,b   Veldhoen, Marc ^b   Phillips, Jenny M ^a   Uyttenhove, Catherine ^c   Stockinger, Brigitta ^b   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 12; INTERLEUKIN 17; MARKER; TRANSCRIPTION FACTOR T BET;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; IN VIVO CULTURE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; SCID MOUSE; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PANCREAS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH17 CELLS; UP-REGULATION; XENOPUS PROTEINS;

EID: 67650650890     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37865     Document Type: Article

References (43)

1. Veldhoen, M., Hocking, R.J., Flavell, R.A., and Stockinger, B. 2006. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7:1151-1156.
2. Li, M.O., Sanjabi, S., and Flavell, R.A. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 25:455-471.
3. Wang, B., et al. 1997. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 94:13844-13849.
4. Nicoletti, F., et al. 1996. The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology. 137:5567-5575.
5. Boyton, R.J., et al. 2005. Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. Int. Immunol. 17:1157-1165.
6. Yang, Z., et al. 2004. Autoimmune diabetes is blocked in Stat4-deficient mice. J. Autoimmun. 22:191-200.
7. Trembleau, S., et al. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
8. Hultgren, B., Huang, X., Dybdal, N., and Stewart, T.A. 1996. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:812-817.
9. Serreze, D.V., et al. 2000. Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes. 49:2007-2011.
10. Kanagawa, O., Xu, G., Tevaarwerk, A., and Vaupel, B.A. 2000. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J. Immunol. 164:3919-3923.
11. Katz, J.D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1089-1100.
12. Mueller, R., Bradley, L.M., Krahl, T., and Sarvetnick, N. 1997. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity. 7:411-418.
13. Phillips, J.M., Parish, N.M., Drage, M., and Cooke, A. 2001. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J. Immunol. 167:6087-6091.
14. You, S., et al. 2007. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. U. S. A. 104:6335-6340.
15. Jain, R., et al. 2008. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205:207-218.
16. Hutchings, P., et al. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 348:639-642.
17. Raine, T., Zaccone, P., Mastroeni, P., and Cooke, A. 2006. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J. Immunol. 177:2224-2233.
18. Streeck, H., et al. 2008. Rapid ex vivo isolation and long-term culture of human Th17 cells. J. Immunol. Methods. 333:115-125.
19. Uyttenhove, C., and Van Snick, J. 2006. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 36:2868-2874.
20. Sonderegger, I., et al. 2006. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 36:2849-2856.
21. Rohn, T.A., et al. 2006. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36:2857-2867.
22. Healey, D., et al. 1995. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979-2985.
23. Katz, J.D., Benoist, C., and Mathis, D. 1995. T helper cell subsets in insulin-dependent diabetes. Science. 268:1185-1188.
24. Park, H., et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
25. Mangan, P.R., et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 441:231-234.
26. Moritani, M., et al. 1998. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. J. Clin. Invest. 102:499-506.
27. Grewal, I.S., et al. 2002. Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J. Autoimmun. 19:9-22.
28. Mathur, A.N., et al. 2006. T-bet is a critical determinant in the instability of the IL-17-secreting Thelper phenotype. Blood. 108:1595-1601.
29. Ivanov, I.I., et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121-1133.
30. Luger, D., et al. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205:799-810.
31. Harrington, L.E., et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
32. Annunziato, F., et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-1861.
33. Lohning, M., et al. 2008. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J. Exp. Med. 205:53-61.
34. Bettelli, E., et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238.
35. Zhou, L., et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 453:236-240.
36. Yang, X.O., et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 29:44-56.
37. Lexberg, M.H., et al. 2008. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 38:2654-2664.
38. Veldhoen, M., et al. 2008. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341-1346.
39. Ymer, S.I., et al. 2002. Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun. 3:151-157.
40. Simpson, P.B., et al. 2003. Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. J. Immunol. 171:3333-3337.
41. Oppmann, B., et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715-725.
42. Murphy, E., et al. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901-913.
43. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., and Stockinger, B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179-189.